Active — Not RecruitingNot Applicable

Prospective Registration Of Patient Data and Quality of Life in Eye Melanoma Patients

Netherlands500 participantsStarted 2019-03-05

Plain-language summary

PROQEM is a prospective cohort study among patients diagnosed with uveal melanoma to assess quality of life before and in the first five years after treatment.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age ≥18 years * Clinical or pathological diagnosis of a melanoma of the choroid or ciliary body * No signs of metastasis after staging procedures with at least an X-thorax, blood test and an ultrasound of the liver * Treatment by brachytherapy, proton therapy or enucleation Exclusion Criteria: * None

What they're measuring

Uveal melanoma-related quality of life

Timeframe: 5 years

Health-related quality of life

Timeframe: 5 years

General quality of life

Timeframe: 5 years

Impact of the diagnosis and treatment of uveal melanoma on mental health

Timeframe: 2 years

Trial details

NCT IDNCT05377957

SponsorLeiden University Medical Center

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2028-04-01

View on ClinicalTrials.gov More Uveal Melanoma trials